PFAS
Phosphoribosylformylglycinamidine synthase
Also known as: FGARAT, GATD8, KIAA0361, PUR4_HUMAN, PURL
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15067
- Gene
- PFAS
- Ensembl
- ENSG00000178921
- Chromosome
- 17
- Canonical length
- 1338 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
Purines are necessary for many cellular processes, including DNA replication, transcription, and energy metabolism. Ten enzymatic steps are required to synthesize inosine monophosphate (IMP) in the de novo pathway of purine biosynthesis. The enzyme encoded by this gene catalyzes the fourth step of IMP biosynthesis. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1338 residues, UniProt reviewed canonical sequence.
>O15067|PFAS
1 MSPVLHFYVR PSGHEGAAPG HTRRKLQGKL PELQGVETEL CYNVNWTAEA LPSAEETKKL
61 MWLFGCPLLL DDVARESWLL PGSNDLLLEV GPRLNFSTPT STNIVSVCRA TGLGPVDRVE
121 TTRRYRLSFA HPPSAEVEAI ALATLHDRMT EQHFPHPIQS FSPESMPEPL NGPINILGEG
181 RLALEKANQE LGLALDSWDL DFYTKRFQEL QRNPSTVEAF DLAQSNSEHS RHWFFKGQLH
241 VDGQKLVHSL FESIMSTQES SNPNNVLKFC DNSSAIQGKE VRFLRPEDPT RPSRFQQQQG
301 LRHVVFTAET HNFPTGVCPF SGATTGTGGR IRDVQCTGRG AHVVAGTAGY CFGNLHIPGY
361 NLPWEDPSFQ YPGNFARPLE VAIEASNGAS DYGNKFGEPV LAGFARSLGL QLPDGQRREW
421 IKPIMFSGGI GSMEADHISK EAPEPGMEVV KVGGPVYRIG VGGGAASSVQ VQGDNTSDLD
481 FGAVQRGDPE MEQKMNRVIR ACVEAPKGNP ICSLHDQGAG GNGNVLKELS DPAGAIIYTS
541 RFQLGDPTLN ALEIWGAEYQ ESNALLLRSP NRDFLTHVSA RERCPACFVG TITGDRRIVL
601 VDDRECPVRR NGQGDAPPTP LPTPVDLELE WVLGKMPRKE FFLQRKPPML QPLALPPGLS
661 VHQALERVLR LPAVASKRYL TNKVDRSVGG LVAQQQCVGP LQTPLADVAV VALSHEELIG
721 AATALGEQPV KSLLDPKVAA RLAVAEALTN LVFALVTDLR DVKCSGNWMW AAKLPGEGAA
781 LADACEAMVA VMAALGVAVD GGKDSLSMAA RVGTETVRAP GSLVISAYAV CPDITATVTP
841 DLKHPEGRGH LLYVALSPGQ HRLGGTALAQ CFSQLGEHPP DLDLPENLVR AFSITQGLLK
901 DRLLCSGHDV SDGGLVTCLL EMAFAGNCGL QVDVPVPRVD VLSVLFAEEP GLVLEVQEPD
961 LAQVLKRYRD AGLHCLELGH TGEAGPHAMV RVSVNGAVVL EEPVGELRAL WEETSFQLDR
1021 LQAEPRCVAE EERGLRERMG PSYCLPPTFP KASVPREPGG PSPRVAILRE EGSNGDREMA
1081 DAFHLAGFEV WDVTMQDLCS GAIGLDTFRG VAFVGGFSYA DVLGSAKGWA AAVTFHPRAG
1141 AELRRFRKRP DTFSLGVCNG CQLLALLGWV GGDPNEDAAE MGPDSQPARP GLLLRHNLSG
1201 RYESRWASVR VGPGPALMLR GMEGAVLPVW SAHGEGYVAF SSPELQAQIE ARGLAPLHWA
1261 DDDGNPTEQY PLNPNGSPGG VAGICSCDGR HLAVMPHPER AVRPWQWAWR PPPFDTLTTS
1321 PWLQLFINAR NWTLEGSCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PFAS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.18
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- spleen: 11 nTPM
- pancreas: 10 nTPM
- kidney: 9.9 nTPM
- liver: 9.5 nTPM
- adrenal gland: 9.3 nTPM
- bone marrow: 9.2 nTPM
Single-cell type
- erythrocyte progenitors: 39 nCPM
- megakaryocyte progenitors: 24 nCPM
- pdcs: 22 nCPM
- differentiating spermatogonia: 21 nCPM
- megakaryocyte-erythroid progenitors: 21 nCPM
- plasma cells: 21 nCPM
Immune cell
- neutrophil: 49 nTPM
- basophil: 20 nTPM
- naive B-cell: 17 nTPM
- memory B-cell: 15 nTPM
- plasmacytoid DC: 13 nTPM
- eosinophil: 13 nTPM
Brain region
- cerebellum: 20 nTPM
- white matter: 19 nTPM
- cerebral cortex: 19 nTPM
- hippocampal formation: 18 nTPM
- basal ganglia: 17 nTPM
- pons: 17 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PFAS.
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 220 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Phosphoribosylformylglycineamidine synthase deficiency
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.77
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.96
- DepMap mean gene effect
- -0.41
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 'de novo' AMP biosynthetic process
- 'de novo' IMP biosynthetic process
- 'de novo' XMP biosynthetic process
- anterior head development
- glutamine metabolic process
- GMP biosynthetic process
- purine nucleotide biosynthetic process
- purine ribonucleoside monophosphate biosynthetic process
- response to xenobiotic stimulus
Molecular functions
- ATP binding
- metal ion binding
- phosphoribosylformylglycinamidine synthase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- PurM-like, C-terminal domain
- Class I glutamine amidotransferase-like
- PurM-like, C-terminal domain superfamily
- PurM-like, N-terminal domain superfamily
- AIR synthase related protein, C-terminal domain
- Phosphoribosylformylglycinamidine synthase PurL
- Phosphoribosylformylglycinamidine synthase subunit PurS-like superfamily
- Phosphoribosylformylglycinamidine synthase, N-terminal
- Phosphoribosylformylglycinamidine synthase, linker domain
- FGAR-AT, PurM N-terminal-like domain
- CobB/CobQ-like glutamine amidotransferase domain
- Formylglycinamide ribonucleotide amidotransferase linker domain
- Formylglycinamide ribonucleotide amidotransferase N-terminal
- FGAR-AT PurM_N-like domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PFAS as an antibody target. Whether an autoantibody or antibody against PFAS could matter depends on whether native PFAS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PFAS is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PFAS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...